Where does Peter Van Vlasselaer work?

Peter Van Vlasselaer is Venture Partner at +ND Capital and Board director at Blade Therapeutics.

What boards does Peter Van Vlasselaer sit on?

Peter Van Vlasselaer holds tracked board seats at Blade Therapeutics, Rgenix.

Peter Van Vlasselaer

Investor

Venture Partner at +ND Capital · Board director at Blade Therapeutics

Find your path to Peter

21 people in our graph share verified history with Peter — schools, employers, funds. One of them is your warm intro.

Luke EvninunlockedPeter: together at Blade Therapeutics

×10Peter: together at +ND Capital

Peter: together at Blade Therapeutics

About

Peter joined +ND Capital in 2019 and was previously founder and CEO of ARMO Biosciences (acquired by Eli Lilly). He has led and co-founded multiple biotech companies and holds a PhD in Immunology.

Contact· self-published, not guessed

p•••@nd.capitalreveal

Board director at Blade Therapeutics

Intro paths

→

In turn, Peter can intro founders to Blade Therapeutics's investors below.

Blade Therapeutics's investors · 7

+ND CapitalWoodside · $540K – $5.4M checks · since 2016 Bay City CapitalSan Rafael · $5M – $10M checks Deerfield Management CompanyNew York MPM BioImpactBoston · $1M – $15M checks · since 2016 Osage University PartnersBala Cynwyd OUP (Osage University Partners)Bala Cynwyd · $1M – $20M checks Pfizer Venture Investments$5M – $20M checks

Deals · 2

RgenixBoard seat

via +ND Capital · filed Feb 2021 · $11M raise

Blade TherapeuticsBoard seat

via +ND Capital · filed Oct 2019 · $50M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at +ND Capital

Aditya Rajagopal

Venture Partner at +ND Capital

Alison Palmer

Vice President of the General Partner at +ND Capital

André Châtelain

Advisor at +ND Capital

Aymeric Sallin

Founder and CEO at +ND Capital

Carl Pabo

Advisor at +ND Capital

Cathleen O’Connor

Executive Assistant at +ND Capital

Eric Moessinger

Partner at +ND Capital

Gabriela Ecco

Principal at +ND Capital

Frequently asked questions

Who is Peter Van Vlasselaer?: Peter joined +ND Capital in 2019 and was previously founder and CEO of ARMO Biosciences (acquired by Eli Lilly). He has led and co-founded multiple biotech companies and holds a PhD in Immunology.
Where does Peter Van Vlasselaer work?: Peter Van Vlasselaer is Venture Partner at +ND Capital and Board director at Blade Therapeutics.
What boards does Peter Van Vlasselaer sit on?: Peter Van Vlasselaer holds tracked board seats at Blade Therapeutics, Rgenix.